Locations:
November 28, 2025/Cancer

Management of Pregnancy-Associated Breast Cancer (Podcast)

Supporting patients during pregnancy and beyond

Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy and after one year after pregnancy. This represents
roughly one in 3,000 pregnancies.

In a recent episode of Cleveland Clinic's Cancer Advances podcast, Erin Roesch, MD, Breast Medical Oncologist discussed:

  • Supporting patients through diagnosis, therapy and recovery
  • How a multidisciplinary team approach helps optimize treatment timing, ensures maternal and fetal safety
  • Managing side effects during pregnancy and chemotherapy
  • Addressing breast feeding during and after treatment

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Click the podcast player above to listen to the episode now.

Podcast excerpt:

Podcast host Dr. Shepard: I'm guessing that managing the complexity of having a breast cancer, coupled with pregnancy, must take a big team. We're going to talk about multidisciplinary care. What does that look like?

Dr. Roesch: Multidisciplinary are includes multiple team members - medical oncologists, breast surgeons, radiation oncologists, genetic counselors, social workers, psychologists, obstetricians, gynecologists and sometimes reproductive providers.

Dr. Shepard: Are there things over time we've learned to do really well?
Where do we need to make improvements?

Dr. Roesch: In terms of some of the psychosocial aspects, we're striving to make improvements and gain a better understanding of the needs of this
population beyond chemotherapy, radiation, and surgery.

It's about having a better understanding of this patient population. Many of these patients may be interested in future pregnancies, so engaging
reproductive endocrinology early on to discuss oncogertility, providing
access to psychologists and social workers, so they're aware that they
have a full team of support. That's an area where continuous improvement
could be made.

And in terms of advances in cancer treatment, how do those advances impact
these patients, whether it's in the systemic therapy realm or in surgical
techniques. There's a lot of room to grow.

Advertisement

Related Articles

Patient and doctor
October 9, 2026/Cancer/News & Insight

First Radioligand Therapy Approved for Metastatic Hormone-Sensitive Prostate Cancer

Adding 177Lu-PSMA-617 to ADT plus an ARPI cut the risk of radiographic progression or mortality by 28%

Woman running
October 7, 2026/Cancer/Patient Support

Pilot Project Aids Cancer Survivors in Achieving Healthy Weight and Reducing Recurrent Risk

New program will help patients improve fitness and manage weight after cancer treatment

Dr Keith McCrae
October 6, 2026/Cancer/Benign Hematology

How is ITP Therapy Evolving?

Cleveland Clinic hematologist highlights new guidelines and treatment advances in immune thrombocytopenia

Bone metastasis
October 5, 2026/Cancer/Innovations

Digital Platform Cuts Bone Metastasis Treatment Decision Time

NIMBLE replaces weekly tumor board delays with same-day multidisciplinary recommendations

Prostate cancer
October 2, 2026/Cancer/Radiation Oncology

ArteraAI Prostate Biomarker Accurate Across Diverse Populations

Cleveland Clinic study provides validation for the test, which combines AI and pathological data to predict outcomes in postoperative patients

Prostate cancer illustration
October 1, 2026/Cancer/Radiation Oncology

PSMA PET Scan-Guided LDR Brachytherapy Can Control Localized Prostate Cancer Recurrence

Advanced imaging technology catches metastases much earlier, allowing treatment with fewer side effects

Throat cancer
September 30, 2026/Cancer/Radiation Oncology

Same Cure Rate, Less Radiation in HPV-Associated Oral Cancer

Reduced radiation for lymph node areas reduces side effects

Lung cancer illustration
September 29, 2026/Cancer/Radiation Oncology

Single-Fraction SBRT Shows Comparable Outcomes to Three-Fraction Approach in Early-Stage Lung Cancer

Large Cleveland Clinic analysis may help resolve a longstanding question over optimal fractionation

Ad